Home
/
Fuse Medical, Inc.
/
Financials
/
Quarterly
Fuse Medical, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Fuse Medical, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2019
Mar 31, 2019
$4.77M
May 7, 2019
Q3
2018
Sep 30, 2018
$6.78M
Nov 13, 2018
Q2
2018
Jun 30, 2018
$5.72M
Aug 20, 2018
Q1
2019
Mar 31, 2018
$6.00M
May 7, 2019
Q3
2018
Sep 30, 2017
$6.01M
Nov 13, 2018
Q2
2018
Jun 30, 2017
$7.30M
Aug 20, 2018
Q1
2018
Mar 31, 2017
$5.59M
May 15, 2018
Q3
2017
Sep 30, 2016
$107.6K
Nov 8, 2017
Q2
2017
Jun 30, 2016
$120.6K
Aug 10, 2017
Q1
2017
Mar 31, 2016
$192.9K
May 11, 2017
Q3
2016
Sep 30, 2015
$442.9K
Nov 14, 2016
Q2
2016
Jun 30, 2015
$487.3K
Aug 15, 2016
Q1
2016
Mar 31, 2015
$262.5K
May 11, 2016
Q3
2015
Sep 30, 2014
$207.1K
Nov 16, 2015
Q2
2015
Jun 30, 2014
$263.3K
Aug 12, 2015
Q1
2015
Mar 31, 2014
$161.6K
May 15, 2015
Q3
2014
Sep 30, 2013
$220.5K
Nov 19, 2014
Q2
2014
Jun 30, 2013
$170.6K
Aug 19, 2014
Q1
2014
Mar 31, 2013
$311.6K
Jul 18, 2014
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2023
Jun 30, 2023
$5.00M
Aug 14, 2023
Q1
2023
Mar 31, 2023
$3.98M
May 15, 2023
Q3
2022
Sep 30, 2022
$4.54M
Nov 14, 2022
Q2
2023
Jun 30, 2022
$4.67M
Aug 14, 2023
Q1
2023
Mar 31, 2022
$4.55M
May 15, 2023
Q3
2022
Sep 30, 2021
$4.25M
Nov 14, 2022
Q2
2022
Jun 30, 2021
$5.67M
Aug 11, 2022
Q1
2022
Mar 31, 2021
$4.44M
May 12, 2022
Q3
2021
Sep 30, 2020
$5.74M
Nov 10, 2021
Q2
2021
Jun 30, 2020
$4.01M
Aug 12, 2021
Q1
2021
Mar 31, 2020
$4.64M
May 12, 2021
Q3
2020
Sep 30, 2019
$5.72M
Nov 16, 2020
Q2
2020
Jun 30, 2019
$5.08M
Aug 7, 2020
Q1
2020
Mar 31, 2019
$4.77M
May 22, 2020
Q3
2019
Sep 30, 2018
$6.78M
Nov 14, 2019
Q2
2019
Jun 30, 2018
$5.72M
Aug 12, 2019
Q1
2019
Mar 31, 2018
$6.00M
Aug 12, 2019
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2023
Jun 30, 2023
$307.6K
Aug 14, 2023
Q2
2023
Mar 31, 2023
($228.4K)
Aug 14, 2023
Q1
2023
Mar 31, 2023
($228.4K)
May 15, 2023
Q3
2022
Sep 30, 2022
($9.4K)
Nov 14, 2022
Q3
2022
Jun 30, 2022
($93.3K)
Nov 14, 2022
Q2
2023
Jun 30, 2022
($322.9K)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($476.4K)
May 15, 2023
Q2
2023
Mar 31, 2022
($476.4K)
Aug 14, 2023
Q3
2022
Mar 31, 2022
($358.3K)
Nov 14, 2022
Q3
2022
Sep 30, 2021
($697.0K)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($85.5K)
Aug 11, 2022
Q3
2022
Jun 30, 2021
($85.5K)
Nov 14, 2022
Q2
2022
Mar 31, 2021
($453.3K)
Aug 11, 2022
Q1
2022
Mar 31, 2021
($453.3K)
May 12, 2022
Q3
2022
Mar 31, 2021
($453.3K)
Nov 14, 2022
Q3
2021
Sep 30, 2020
$80.5K
Nov 10, 2021
Q2
2021
Jun 30, 2020
($423.4K)
Aug 12, 2021
Q3
2021
Jun 30, 2020
($423.4K)
Nov 10, 2021
Q2
2021
Mar 31, 2020
($1.28M)
Aug 12, 2021
Q1
2021
Mar 31, 2020
($1.28M)
May 12, 2021
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2023
Jun 30, 2023
$368.9K
Aug 14, 2023
Q1
2023
Mar 31, 2023
($165.6K)
May 15, 2023
Q3
2022
Sep 30, 2022
$44.9K
Nov 14, 2022
Q2
2022
Jun 30, 2022
($51.6K)
Aug 11, 2022
Q1
2023
Mar 31, 2022
($438.6K)
May 15, 2023
Q3
2022
Sep 30, 2021
($681.0K)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($426.0K)
Aug 11, 2022
Q1
2022
Mar 31, 2021
($430.0K)
May 12, 2022
Q3
2021
Sep 30, 2020
$106.8K
Nov 10, 2021
Q2
2021
Jun 30, 2020
($398.5K)
Aug 12, 2021
Q1
2021
Mar 31, 2020
($1.25M)
May 12, 2021
Q3
2020
Sep 30, 2019
($3.10M)
Nov 16, 2020
Q2
2020
Jun 30, 2019
($154.5K)
Aug 7, 2020
Q1
2020
Mar 31, 2019
($600.1K)
May 22, 2020
Q3
2019
Sep 30, 2018
$394.1K
Nov 14, 2019
Q2
2019
Jun 30, 2018
($1.96M)
Aug 12, 2019
Q1
2019
Mar 31, 2018
($896.7K)
Aug 12, 2019
Q3
2018
Sep 30, 2017
$551.8K
Nov 13, 2018
Q2
2018
Jun 30, 2017
$652.9K
Aug 20, 2018
Q1
2018
Mar 31, 2017
($536.3K)
May 15, 2018